| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenue | ||||||
67,301 | - | - | ||||
Revenue | ||||||
- | 55,380 | 47,983 | ||||
Cost of goods sold | ||||||
6,790 | 4,833 | 5,112 | ||||
Gross profit | ||||||
60,511 | 50,547 | 42,871 | ||||
Operating expenses: | ||||||
Sales and marketing | ||||||
68,251 | 44,497 | 41,646 | ||||
Research and development | ||||||
7,279 | 5,376 | 5,513 | ||||
General and administrative | ||||||
20,984 | 12,639 | 13,062 | ||||
Total operating expenses | ||||||
96,514 | 62,512 | 60,221 | ||||
Loss from operations | ||||||
-36,003 | -11,965 | -17,350 | ||||
Interest and other income (expense), net: | ||||||
Interest income | ||||||
2,551 | 769 | 175 | ||||
Interest expense | ||||||
4,949 | 5,108 | 6,204 | ||||
Other expense, net | ||||||
-2 | -1,149 | 340 | ||||
Net loss | ||||||
-38,403 | -17,453 | -23,039 | ||||
Other comprehensive income (loss): | ||||||
Changes in foreign currency translation | ||||||
-19 | 27 | -70 | ||||
Unrealized gain on marketable securities | ||||||
44 | 10 | 0 | ||||
Comprehensive loss | ||||||
-38,378 | -17,416 | -23,109 | ||||
Net loss per share, basic and diluted (in dollars per share) | ||||||
-1.55 | -2.20 | -6.65 | ||||
Weighted-average number of common shares used to compute basic and diluted net loss per share (in shares) | ||||||
24,705 | 7,950 | 3,467 | ||||